In times of political and social upheaval, maintaining our links across borders and working closely together is more important than ever.

Sitting Down With… Brian Henry, Vice President of Drug Product Design, Pharmaceutical Sciences department at Pfizer.

Continuous wet granulation will be the star of a new UK facility, which stems from a collaboration between CPI, GSK and AstraZeneca.

Will antibody drug conjugates live up to the ever-growing expectations surrounding them?

A number of aspects must be considered to design a tablet that is well suited for commercial manufacture.

Biopharma manufacturers have been using the same assays for viral safety testing for decades.

With many APIs exhibiting a strong, bitter taste, taste-masking is essential, particularly for pediatric patients.

The tablet press is a pharma manufacturing facility staple, but today’s systems need to be faster, more reliable and more flexible than ever before.

With a no-deal Brexit still a real possibility, Merck continues to prepare for the worst case scenario.

Claudia Zylberberg reveals her career lessons learned and offers her perspective on the now booming advanced therapies industry.